Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-21 Sale |
2025-03-24 9:00 pm |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
33,545 | $1.35 | $45,286 | 140,045 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-04 6:11 pm |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
27,410 | $1.85 | $50,709 | 73,590 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Exercise |
2025-03-19 7:29 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
100,000 | $0 | 173,590 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 4:28 pm |
N/A 2035-03-03 |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
757,915 | $0 | 757,915 (Direct) |
View |
| 2024-10-04 Option Award |
2024-10-04 4:30 pm |
N/A 2030-08-20 |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
441,568 | $0 | 441,568 (Direct) |
View |
| 2024-03-14 Exercise |
2024-03-15 8:16 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
100,000 | $0 | 751,000 (Direct) |
View |
| 2024-03-13 Option Award |
2024-03-15 8:16 pm |
N/A 2034-03-13 |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer |
550,000 | $0 | 751,000 (Direct) |
View |
Ownership |
2023-05-19 5:36 pm |
N/A N/A |
ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Accounting Officer |
0 | $0 | 1,414,188 (Direct) |
View |